Connect with us

Health and Medicine

Schizophrenia: 10 new genes involved have been identified

Published

on

In one of the largest studies on DNA sequencing associated with schizophrenia, a group of researchers led by Tarjinder Singh discovered 10 new genes involved in the development of this disease using a method called “whole exome sequencing.” The researchers used the genetic data of more than 125,000 people to obtain different information about the genetic basis of the same schizophrenia. The research results were then presented at the annual meeting of the American Society of Human Genetics 2019 in Houston.

One of the reasons why researchers have used DNA sequencing to obtain information about schizophrenia is that there has been limited progress in the development of new schizophrenia drugs over the past 50 years. However, the use of new genetic techniques has proved very useful in many areas in recent years, and researchers themselves believe that useful results can be obtained to discover the mechanisms of schizophrenia.

The latter is one of the psychiatric disorders not yet fully understood. However, it is believed that its development can be accelerated by disorders of certain genes encoding certain proteins.
It is precisely because these are rare genetic changes that researchers have used a very large number of people. Of the 125,000 people tested, 25,000 were diagnosed with schizophrenia. People came from all five continents.

After the analysis, the researchers identified 10 genes that, once they stopped functioning, caused an increased risk of schizophrenia, according to Singh himself in the press release. Two of these 10 genes encode glutamate receptors, suggesting that these receptors may be a target for future schizophrenia therapies.

LINKS AND SOURCES

https://www.ashg.org/press/201910-scz.shtml

https://eventpilotadmin.com/web/page.php?page=IntHtml&project=ASHG19&id=1922937

IMAGE CREDIT

https://i.ytimg.com/vi/ENkzVbvMUCU/maxresdefault.jpg

Bob Miller

Bob was Professor of Behavioural Neuroscience at the University of Denver from 2011-2018 and now works as a practicing psychiatrist. As a passionate scientist, he founded the website www.healthmongers.org in early 2019 with the goal of delivering accurate and useful scientific reporting, and has since built it up as a valuable publication. While his field is in psychology, Bob also has a strong general understanding of many other fields in health, astronomy and applied science, and is able to write in a way that is easily understandable to the layman.

2930 Scheuvront Drive, Denver Colorado, 80211
303-458-7258
[email protected]
Bob Miller
Continue Reading

Health and Medicine

New blood collection robot uses artificial intelligence to detect veins

Published

on

A new tabletop robot to draw blood or insert catheters to deliver drugs and fluids was created by a group of engineers at Rutgers University. According to the press release, this robot uses artificial intelligence and infrared and ultrasound imaging technologies to guide needles or catheters with extreme precision into even the smallest blood vessels with minimal human supervision.

The new robot, described in a study published in Nature Machine Intelligence, arrives in a sector, that of blood sampling or the introduction of medicines into the blood itself, which is revolutionizing in recent years thanks to the advent of robotics and artificial intelligence.
Today, these robots can perform fairly complex medical tasks and can improve the results of procedures.

The new robot has already been tested on animals and volunteers and has proven to be able to accurately identify even the smallest blood vessels, which in itself improves the success rates and the total time of the procedure, even for the most experienced professionals, as explained by Martin L. Yarmush, professor in the Department of Biomedical Engineering at Rutgers and senior author of the study.

One of the most difficult steps when it comes to taking blood or putting medication into the blood itself is to detect the veins and arteries. Very often even the most experienced health care professionals fail at the first attempt (or even at the next attempt) because the blood vessels can be small, twisted, collapsed on themselves, etc., situations that are even more present in chronically ill or traumatized people.

Very often at least five attempts are necessary, which delays treatment and is certainly not appreciated by the patient himself.
In addition, multiple attempts can perforate larger arteries than nerves or adjacent internal organs, which naturally increases the risk of complications.

Instead, this new robot or guide the lake or catheter precisely by identifying, through ultrasound imaging and using artificial intelligence, the blood vessels, distinguishing them from the surrounding tissue and classifying and estimating them by depth and level of adaptation to the operation.

“Not only can the device be used for patients, but it can also be modified to draw blood from rodents, a procedure that is extremely important for animal drug testing in the pharmaceutical and biotech industries,” Yarmush himself reports.

Bob Miller

Bob was Professor of Behavioural Neuroscience at the University of Denver from 2011-2018 and now works as a practicing psychiatrist. As a passionate scientist, he founded the website www.healthmongers.org in early 2019 with the goal of delivering accurate and useful scientific reporting, and has since built it up as a valuable publication. While his field is in psychology, Bob also has a strong general understanding of many other fields in health, astronomy and applied science, and is able to write in a way that is easily understandable to the layman.

2930 Scheuvront Drive, Denver Colorado, 80211
303-458-7258
[email protected]
Bob Miller
Continue Reading

Health and Medicine

Diabetes: scientists discover new therapeutic options to limit collateral damage caused by insulin

Published

on

A protein that can act as a regulator of blood sugar and lipids under certain conditions has been identified by a group of researchers at the University of Geneva (UNIGE). The protein, called S100A9, could counteract the side effects of insulin administered to diabetics.

The study published in Nature Communications mentions what a new treatment for diabetes and in general a significant improvement in the quality of life of tens of millions of people could be. In fact, millions of people with type 1 and type 2 diabetes have to resort to insulin injections. Overdose can cause hypoglycemia, a drop in blood glucose levels, while underdose can lead to dangerous hyperglycemia.

In experiments on mice, scientists found that the administration of S100A9 to insulin-deficient diabetic rats led to better glucose management and better control of ketones and lipids. They then discovered that this protein appears to work only when there is TLR4, a receptor placed on the membrane of certain cells, including adipocytes and immune system cells.

Now Roberto Coppari, one of the authors of the study together with Giorgio Ramadori, and his team want to understand the function of the protein S100A9. In this context, they are developing a new treatment that combines low doses of insulin and S100A9 to understand whether it is possible to better control glucose and ketones and limit the same negative side effect of insulin.

“We also want to decipher the exact role of TLR4 to offer a therapeutic strategy that achieves the delicate balance between blood sugar, ketones and optimal lipid control,” explains Coppari himself in the press release.

LINKS AND SOURCES

https://www.unige.ch/communication/communiques/en/2019/diabete-des-traitements-de-nouvelle-generation-bientot-disponibles/

https://www.nature.com/articles/s41467-019-11498-x

IMAGE CREDIT

https://www.franciscanhealth.org/sites/default/files/2015/10/20/hero-diabetes-managemetn-tools-and-veggies.jpg

Bob Miller

Bob was Professor of Behavioural Neuroscience at the University of Denver from 2011-2018 and now works as a practicing psychiatrist. As a passionate scientist, he founded the website www.healthmongers.org in early 2019 with the goal of delivering accurate and useful scientific reporting, and has since built it up as a valuable publication. While his field is in psychology, Bob also has a strong general understanding of many other fields in health, astronomy and applied science, and is able to write in a way that is easily understandable to the layman.

2930 Scheuvront Drive, Denver Colorado, 80211
303-458-7258
[email protected]
Bob Miller
Continue Reading

Health and Medicine

Children of mothers who have taken snus during pregnancy show higher blood pressure.

Published

on

A research team found that children between the ages of five and six whose mothers had used snus during pregnancy had higher systolic blood pressure. The new study was published in the Journal of the American Heart Association.

Snus is a moist powdered tobacco for oral use that was banned in the European Union as early as 1992 after World Health Organization studies found it to be carcinogenic. However, this tobacco is very popular in some countries, such as Sweden, and is still available in the United States (although it is currently processed by the FDA in that country).

The snus is placed between the gums and the upper lip and essentially provides nicotine. The advantage of using such tobacco would be that it does not include the by-products of burning classic cigarettes. Another advantage is that it is not necessary to spit, as is the case with most common chewing tobacco cards.

This study shows that the intake of nicotine during pregnancy, whether from cigarettes, chewing tobacco or snus, is not safe and can have negative effects on the unborn child, as Felicia Nordenstam, a paediatric cardiologist at the Karolinska Institute University Hospital in Stockholm and lead author of the study, explains.

The researcher analyzed data from children born to 21 women who used only snus during pregnancy and compared it with data from 19 children whose mothers did not consume tobacco products during pregnancy.

Researchers found that systolic blood pressure in children in the first group was 4.2 mmHg higher than in children in the second group.

LINKS AND SOURCES

https://medicalxpress.com/news/2019-10-children-higher-blood-pressure-age.html

https://www.ahajournals.org/doi/10.1161/JAHA.119.012629

IMAGE CREDIT

https://images.newscientist.com/wp-content/uploads/2017/03/14161245/e2d3ay.jpg

Bob Miller

Bob was Professor of Behavioural Neuroscience at the University of Denver from 2011-2018 and now works as a practicing psychiatrist. As a passionate scientist, he founded the website www.healthmongers.org in early 2019 with the goal of delivering accurate and useful scientific reporting, and has since built it up as a valuable publication. While his field is in psychology, Bob also has a strong general understanding of many other fields in health, astronomy and applied science, and is able to write in a way that is easily understandable to the layman.

2930 Scheuvront Drive, Denver Colorado, 80211
303-458-7258
[email protected]
Bob Miller
Continue Reading

Support Health Mongers

If you enjoy our reporting, please consider a small donation via PayPal to [email protected] - even a small amount of $5 or $10 will help out significantly with our hosting costs. You can also share our articles on Facebook, Reddit and Twitter. Also make sure to sign up to our newsletter to get notified whenever we publish a new article.

Trending